Bruton's tyrosine kinase inhibition reduces disease severity in a model of secondary progressive autoimmune demyelination.
Evonuk KS, Wang S, Mattie J, Cracchiolo CJ, Mager R, Ferenčić Ž, Sprague E, Carrier B, Schofield K, Martinez E, Stewart Z, Petrosino T, Johnson GA, Yusuf I, Plaisted W, Naiman Z, Delp T, Carter L, Marušić S.
Evonuk KS, et al.
Acta Neuropathol Commun. 2023 Jul 12;11(1):115. doi: 10.1186/s40478-023-01614-w.
Acta Neuropathol Commun. 2023.
PMID: 37438842
Free PMC article.